Target intelligence / Profile preview

Neisseria meningitidis serogroup W capsular polysaccharide antigen-conjugated protein carrier

Molecular classification
Polysaccharide antigen, Protein conjugate
01

Overview

The capsular polysaccharide antigen from Neisseria meningitidis serogroup W, chemically conjugated to a protein carrier (e.g., CRM197 or outer membrane proteins). This construct is used in vaccines to enhance immunogenicity and elicit a protective antibody response against invasive disease caused by serogroup W strains. Conjugation converts the T-cell-independent polysaccharide antigen into a T-cell-dependent antigen, resulting in improved immune responses, particularly in infants and young children.

Other names
Serogroup W polysaccharide-protein conjugateN. meningitidis serogroup W conjugate vaccine antigen
02

Mechanism of action

Stimulates T-cell dependent antibody production against the N. meningitidis serogroup W capsular polysaccharide

03

Biological functions

Evasion of host immunityInduction of protective antibody responseVaccine antigen
04

Disease associations

InfectionMeningococcal disease
05

Safety considerations

Local injection site reactionsRare cases of allergic reactions
06

Interacting drugs

Meningococcal conjugate vaccines (e.g., MenACWY)
07

Biomarkers

Anti-capsular polysaccharide antibody titersOpsonophagocytic activity (OPA) assay results

Beyond the preview

Go deeper on Neisseria meningitidis serogroup W capsular polysaccharide antigen-conjugated protein carrier.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neisseria meningitidis serogroup W capsular polysaccharide antigen-conjugated protein carrier.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call